SWTX logo

SpringWorks Therapeutics (SWTX) Cash from investing

annual CFI:

$64.55M+$29.79M(+85.72%)
December 31, 2024

Summary

  • As of today (July 1, 2025), SWTX annual cash flow from investing activities is $64.55 million, with the most recent change of +$29.79 million (+85.72%) on December 31, 2024.
  • During the last 3 years, SWTX annual CFI has fallen by -$19.05 million (-22.79%).
  • SWTX annual CFI is now -22.79% below its all-time high of $83.59 million, reached on December 31, 2021.

Performance

SWTX Cash from investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSWTXcash flow metrics

quarterly CFI:

$73.39M+$59.25M(+418.86%)
March 31, 2025

Summary

  • As of today (July 1, 2025), SWTX quarterly cash flow from investing activities is $73.39 million, with the most recent change of +$59.25 million (+418.86%) on March 31, 2025.
  • Over the past year, SWTX quarterly CFI has increased by +$51.93 million (+241.95%).
  • SWTX quarterly CFI is now -25.57% below its all-time high of $98.60 million, reached on March 31, 2023.

Performance

SWTX quarterly CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSWTXcash flow metrics

TTM CFI:

$116.47M+$51.93M(+80.46%)
March 31, 2025

Summary

  • As of today (July 1, 2025), SWTX TTM cash flow from investing activities is $116.47 million, with the most recent change of +$51.93 million (+80.46%) on March 31, 2025.
  • Over the past year, SWTX TTM CFI has increased by +$158.86 million (+374.79%).
  • SWTX TTM CFI is now -40.45% below its all-time high of $195.59 million, reached on September 30, 2022.

Performance

SWTX TTM CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSWTXcash flow metrics

Cash from investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

SWTX Cash from investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+85.7%+241.9%+374.8%
3 y3 years-22.8%+177.8%-17.4%
5 y5 years+1615.1%+10000.0%+269.5%

SWTX Cash from investing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-22.8%+129.9%-25.6%+120.7%-40.5%+154.0%
5 y5-year-22.8%+115.4%-25.6%+120.7%-40.5%+125.9%
alltimeall time-22.8%+115.4%-25.6%+120.7%-40.5%+125.9%

SWTX Cash from investing History

DateAnnualQuarterlyTTM
Mar 2025
-
$73.39M(+418.9%)
$116.47M(+80.5%)
Dec 2024
$64.55M(+85.7%)
$14.14M(-50.6%)
$64.55M(-159.3%)
Sep 2024
-
$28.65M(+9812.8%)
-$108.81M(+5.8%)
Jun 2024
-
$289.00K(-98.7%)
-$102.85M(+142.7%)
Mar 2024
-
$21.46M(-113.5%)
-$42.39M(-222.0%)
Dec 2023
$34.75M(-116.1%)
-$159.21M(-560.1%)
$34.75M(-121.6%)
Sep 2023
-
$34.60M(-43.1%)
-$161.05M(+47.2%)
Jun 2023
-
$60.76M(-38.4%)
-$109.42M(-23.7%)
Mar 2023
-
$98.60M(-127.8%)
-$143.42M(-33.5%)
Dec 2022
-$215.60M(-357.9%)
-$355.01M(-511.7%)
-$215.60M(-210.2%)
Sep 2022
-
$86.23M(+222.3%)
$195.59M(+34.8%)
Jun 2022
-
$26.76M(+1.3%)
$145.15M(+3.0%)
Mar 2022
-
$26.42M(-53.0%)
$140.93M(+68.6%)
DateAnnualQuarterlyTTM
Dec 2021
$83.59M(-120.0%)
$56.18M(+57.0%)
$83.59M(-142.8%)
Sep 2021
-
$35.78M(+58.7%)
-$195.37M(-45.5%)
Jun 2021
-
$22.54M(-172.9%)
-$358.72M(-20.2%)
Mar 2021
-
-$30.92M(-86.1%)
-$449.59M(+7.3%)
Dec 2020
-$418.83M(+9731.7%)
-$222.78M(+74.6%)
-$418.83M(+113.5%)
Sep 2020
-
-$127.56M(+86.7%)
-$196.18M(+185.6%)
Jun 2020
-
-$68.33M(>+9900.0%)
-$68.70M(+1551.9%)
Mar 2020
-
-$160.00K(+23.1%)
-$4.16M(-2.4%)
Dec 2019
-$4.26M(+1353.9%)
-$130.00K(+54.8%)
-$4.26M(+3.1%)
Sep 2019
-
-$84.00K(-97.8%)
-$4.13M(+2.1%)
Jun 2019
-
-$3.79M(+1350.2%)
-$4.05M(+1450.2%)
Mar 2019
-
-$261.00K
-$261.00K
Dec 2018
-$293.00K
-
-

FAQ

  • What is SpringWorks Therapeutics annual cash flow from investing activities?
  • What is the all time high annual CFI for SpringWorks Therapeutics?
  • What is SpringWorks Therapeutics annual CFI year-on-year change?
  • What is SpringWorks Therapeutics quarterly cash flow from investing activities?
  • What is the all time high quarterly CFI for SpringWorks Therapeutics?
  • What is SpringWorks Therapeutics quarterly CFI year-on-year change?
  • What is SpringWorks Therapeutics TTM cash flow from investing activities?
  • What is the all time high TTM CFI for SpringWorks Therapeutics?
  • What is SpringWorks Therapeutics TTM CFI year-on-year change?

What is SpringWorks Therapeutics annual cash flow from investing activities?

The current annual CFI of SWTX is $64.55M

What is the all time high annual CFI for SpringWorks Therapeutics?

SpringWorks Therapeutics all-time high annual cash flow from investing activities is $83.59M

What is SpringWorks Therapeutics annual CFI year-on-year change?

Over the past year, SWTX annual cash flow from investing activities has changed by +$29.79M (+85.72%)

What is SpringWorks Therapeutics quarterly cash flow from investing activities?

The current quarterly CFI of SWTX is $73.39M

What is the all time high quarterly CFI for SpringWorks Therapeutics?

SpringWorks Therapeutics all-time high quarterly cash flow from investing activities is $98.60M

What is SpringWorks Therapeutics quarterly CFI year-on-year change?

Over the past year, SWTX quarterly cash flow from investing activities has changed by +$51.93M (+241.95%)

What is SpringWorks Therapeutics TTM cash flow from investing activities?

The current TTM CFI of SWTX is $116.47M

What is the all time high TTM CFI for SpringWorks Therapeutics?

SpringWorks Therapeutics all-time high TTM cash flow from investing activities is $195.59M

What is SpringWorks Therapeutics TTM CFI year-on-year change?

Over the past year, SWTX TTM cash flow from investing activities has changed by +$158.86M (+374.79%)
On this page